Protak Scientific, the UK company leading the introduction of a revolutionary new science in decontamination validation worldwide, the Enzyme Indicator, have appointed Netsteril to bring the [...]

By Phillip Godden, CEO, Protak Scientific First off, thanks for taking a few moments to click through and read more. I wanted to pen a few words about me, this technology and the excitement it [...]

Biological indicators were the foremost method of assessing the sterility of any medical or pharmaceutical environment through the use of some of the most resistant microorganism strains (eg. [...]

So where can the use of Enzyme Indicators for decontamination validation bring real value? Here we discuss some key areas where this new science will revolutionise current processes…   [...]

Read what Protak’s CEO Phillip Godden has to say about his company, the new Enzyme Indicator technology and why he is so passionate to bring it to market worldwide…   So what do [...]

The sterility test / verification of the performance of hydrogen peroxide decontamination is a vital process – yet the gold standard of Biological Indicators is incredibly flawed. With the [...]

Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control – UPDATED April 2, 2015 FDA has alerted healthcare professionals and the public about multiple sterile [...]

The North Carolina Board of Pharmacy has ordered a recall for all lots of non-sterile and sterile products compounded, repackaged and distributed by Prescription Center Pharmacy located at 915 [...]

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) [...]

As part of the continual commitment to further research on Enzyme Indicators, Protak have commissioned Public Health England to further study tAK Enzyme Indicators

FDA PRESS RELEASE, FOR IMMEDIATE RELEASE — March 11, 2015 — LAKE FOREST, Ill. — Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary recall of one lot of Lactated [...]

ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of [...]

FDA PRESS, FOR IMMEDIATE RELEASE — February 24, 2015 — Eatontown, NJ, Heritage Pharmaceuticals Inc. (Heritage) today announced the voluntary nationwide recall of ten (10) lots of Colistimethate [...]

ITH Pharma Ltd is recalling specific batches of Lipid Phase Parenteral Nutrition from specific hospitals. This is because of a potential contamination with Bacillus cereus identified following a [...]